These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25005586)

  • 21. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum.
    Stoller NH; Johnson LR; Trapnell S; Harrold CQ; Garrett S
    J Periodontol; 1998 Oct; 69(10):1085-91. PubMed ID: 9802705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local antimicrobial therapies in periodontal disease.
    Kinane DF
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced topical drug delivery system for the management of vaginal candidiasis.
    Johal HS; Garg T; Rath G; Goyal AK
    Drug Deliv; 2016; 23(2):550-63. PubMed ID: 24959937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RGD functionalized polymeric nanoparticles targeting periodontitis epithelial cells for the enhanced treatment of periodontitis in dogs.
    Yao W; Xu P; Zhao J; Ling L; Li X; Zhang B; Cheng N; Pang Z
    J Colloid Interface Sci; 2015 Nov; 458():14-21. PubMed ID: 26197107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characteristics of thermoresponsive gel of minocycline hydrochloride and evaluation of its effect on experimental periodontitis models.
    Ruan H; Yu Y; Liu Y; Ding X; Guo X; Jiang Q
    Drug Deliv; 2016; 23(2):525-31. PubMed ID: 24963751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline microspheres: a complementary medical-mechanical model for the treatment of chronic periodontitis.
    Paquette DW
    Compend Contin Educ Dent; 2002 May; 23(5 Suppl):15-21. PubMed ID: 12789964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: role of controlled drug delivery for periodontitis (position paper). The American Academy of Periodontology (2000;71:12-40).
    Finkelman RD
    J Periodontol; 2000 Dec; 71(12):1929-33. PubMed ID: 11156051
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
    Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
    Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiological and clinical effects of a 1% chlorhexidine-gel in untreated periodontal pockets from adult periodontitis patients.
    Piccolomini R; Di Bonaventura G; Catamo G; Tumini V; Di Placido G; D'Ercole S; Perfetti G; Paolantonio M
    New Microbiol; 1999 Apr; 22(2):111-6. PubMed ID: 10322610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Bioactive and Therapeutic Dental Polymeric Materials to Inhibit Periodontal Pathogens and Biofilms.
    Chi M; Qi M; A L; Wang P; Weir MD; Melo MA; Sun X; Dong B; Li C; Wu J; Wang L; Xu HHK
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying oral irrigation devices for subgingival periodontal chemotherapy.
    Rams TE; Keyes PH
    Gen Dent; 1984; 32(4):302-5. PubMed ID: 6590410
    [No Abstract]   [Full Text] [Related]  

  • 35. Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy.
    Goodson JM; Gunsolley JC; Grossi SG; Bland PS; Otomo-Corgel J; Doherty F; Comiskey J
    J Periodontol; 2007 Aug; 78(8):1568-79. PubMed ID: 17668977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis.
    Kelly HM; Deasy PB; Ziaka E; Claffey N
    Int J Pharm; 2004 Apr; 274(1-2):167-83. PubMed ID: 15072793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local drug delivery systems in the management of periodontitis: A scientific review.
    H R R; Dhamecha D; Jagwani S; Rao M; Jadhav K; Shaikh S; Puzhankara L; Jalalpure S
    J Control Release; 2019 Aug; 307():393-409. PubMed ID: 31255689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatments hold perio promise.
    Jones DG
    J Calif Dent Assoc; 1998 Dec; 26(12):882-4. PubMed ID: 10388438
    [No Abstract]   [Full Text] [Related]  

  • 39. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological evaluation of the effects of hyperbaric oxygen on periodontal disease.
    Signoretto C; Bianchi F; Burlacchini G; Canepari P
    New Microbiol; 2007 Oct; 30(4):431-7. PubMed ID: 18080679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.